Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend down since Sep 29 · above the Ichimoku cloud · RSI 57 · MACD below its signal
None of the 29 investors followed here reported a position in VSEED in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a VSEED trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for VSEED.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.5 | 2.2 | -32.2 | -24.4 | 0.5 | -38.9 | -31.9 | -81.0 | 14900.0 | -26.7 | +341.2% | ||
| 2025 | 23.5 | -10.1 | -20.5 | 3.3 | 1.6 | -7.9 | 11.2 | -53.5 | 1.7 | 59.8 | -42.6 | -33.2 | −72.5% |
| 2024 | 0.0 | -3.8 | 0.4 | 1.8 | 41.7 | -48.5 | -73.1 | -38.3 | 2.8 | 8.7 | 29.6 | -35.2 | −88.9% |
| 2023 | -1.7 | 3.6 | 1.1 | 0.1 | 1.7 | 1.9 | 0.0 | 3.0 | -0.8 | -0.9 | 7.8 | -4.1 | +11.9% |
| 2022 | 0.2 | 0.6 | 0.4 | 0.3 | -0.1 | 0.1 | 0.3 | 0.4 | 0.3 | 4.1 | -0.2 | 3.5 | +10.3% |
| 2021 | — |
No analyst coverage for this instrument.
VSee Health, Inc. provides telehealth care solutions in the United States. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. It also provides telehealth software building blocks, such as patient engagement, clinician staffing, remote physical exam and remote patient monitoring, and AI for telesitter and telenursing solutions; data connectors; and workflow templates. The company distributes its products through third-party resellers and affiliated hospitals, as well as sales executives. The company is headquartered in Newton, Massachusetts.
No recent headlines.